This protocol addresses male patients diagnosed with hereditary spinocerebellar ataxia who present with erectile dysfunction. Sexual function is a recognized area requiring clinical attention in patients with ataxia, and discussion about erectile dysfunction should be included as part of their overall consultation.
Erectile dysfunction can occur in patients with hereditary spinocerebellar ataxia as well as other ataxia types. Addressing it as part of comprehensive ataxia management is clinically appropriate. Where indicated, targeted treatment is available.
A specific pharmacological class is the established first-line approach for erectile dysfunction in this population. The full structured regimen — including agent selection, relevant cautions, and the complete clinical algorithm — is available via the protocol below.
Erectile dysfunction can also occur in patients with other ataxias and discussion about sexual function should therefore be included in their consultation.
Phosphodiesterase-5 inhibitors are the mainstay of treatment, eg. sildenafil, tadalafil and vardenafil.
Treat erectile dysfunction where appropriate with phosphodiesterase-5 inhibitors.
View source ↗